First trial of 'base editing' in humans lowers cholesterol — but raises safety concerns - Nature.com
- First trial of 'base editing' in humans lowers cholesterol — but raises safety concerns Nature.com
- Gene-editing tool could help lower high cholesterol in patients NBC News
- Crispr Offers Hope for a One-Time Cholesterol Drug Bloomberg
- One-time CRISPR treatment could permanently lower cholesterol New Scientist
- A Single Infusion of a Gene-Editing Treatment Lowered High Cholesterol WIRED
- View Full Coverage on Google News